Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer
David Bader, Sean M. Hartig, Vasanta Putluri, et al.
Nature Metabolism (2018) Vol. 1, Iss. 1, pp. 70-85
Open Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

Mitochondrial spare respiratory capacity: Mechanisms, regulation, and significance in non‐transformed and cancer cells
Philippe Marchetti, Quentin Fovez, Nicolas Germain, et al.
The FASEB Journal (2020) Vol. 34, Iss. 10, pp. 13106-13124
Closed Access | Times Cited: 223
Metabolic Codependencies in the Tumor Microenvironment
Prasenjit Dey, Alec C. Kimmelman, Ronald A. DePinho
Cancer Discovery (2021) Vol. 11, Iss. 5, pp. 1067-1081
Open Access | Times Cited: 150
2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer
Arnaud Blomme, Catriona A. Ford, Ernest Mui, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 149
Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier
Claire Bensard, Dona R. Wisidagama, Kristofor A. Olson, et al.
Cell Metabolism (2019) Vol. 31, Iss. 2, pp. 284-300.e7
Open Access | Times Cited: 148
Metabolic reprogramming in prostate cancer
Fahim Ahmad, Murali Cherukuri, Peter L. Choyke
British Journal of Cancer (2021) Vol. 125, Iss. 9, pp. 1185-1196
Open Access | Times Cited: 138
Tumour metabolism and its unique properties in prostate adenocarcinoma
David Bader, Sean E. McGuire
Nature Reviews Urology (2020) Vol. 17, Iss. 4, pp. 214-231
Closed Access | Times Cited: 119
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications
Ugo Testa, Germana Castelli, Elvira Pelosi
Medicines (2019) Vol. 6, Iss. 3, pp. 82-82
Open Access | Times Cited: 118
OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation
Bernd Schöpf, Hansi Weißensteiner, Georg Schäfer, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 109
The Multifaceted Pyruvate Metabolism: Role of the Mitochondrial Pyruvate Carrier
Joséphine Zangari, Francesco Petrelli, Benoît Maillot, et al.
Biomolecules (2020) Vol. 10, Iss. 7, pp. 1068-1068
Open Access | Times Cited: 109
Impact of cancer metabolism on therapy resistance – Clinical implications
Ana Cristina Gonçalves, Elena Richiardone, Joana Jorge, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100797-100797
Open Access | Times Cited: 90
Mitochondria: The metabolic switch of cellular oncogenic transformation
Yan Qin Tan, Xi Zhang, Shuwei Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 1, pp. 188534-188534
Closed Access | Times Cited: 66
The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17
Daniele Chaves‐Moreira, Marilyn A. Mitchell, Cristina Arruza, et al.
Science Signaling (2022) Vol. 15, Iss. 728
Open Access | Times Cited: 39
Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
Francesco Lasorsa, Nicola Antonio di Meo, Monica Rutigliano, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 910-910
Open Access | Times Cited: 31
Synchronous Interventions of Glucose and Mitochondrial Metabolisms for Antitumor Bioenergetic Therapy
Meng Li, Xiaoming Luo, Lei Shan, et al.
Advanced Materials (2023) Vol. 35, Iss. 29
Closed Access | Times Cited: 26
Preclinical models of prostate cancer — modelling androgen dependency and castration resistance in vitro, ex vivo and in vivo
Lucas Germain, Camille Lafront, Virginie Paquette, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 8, pp. 480-493
Closed Access | Times Cited: 24
The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression
Camille Lafront, Lucas Germain, Gabriel Henrique Campolina-Silva, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 11
Open Access | Times Cited: 13
Metabolic adaptations in prostate cancer
Mikel Pujana-Vaquerizo, Laura Bozal-Basterra, Arkaitz Carracedo
British Journal of Cancer (2024) Vol. 131, Iss. 8, pp. 1250-1262
Open Access | Times Cited: 13
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies
Giulia Ambrosini, Marco Cordani, Ali Zarrabi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcoma
Enrico Pozzo, Laura Yedigaryan, Nefele Giarratana, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115171-115171
Open Access | Times Cited: 1
Lactylation in cancer: metabolic mechanism and therapeutic strategies
Ying Sui, Ziyang Shen, Zhenling Wang, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Disrupting Mitochondrial Pyruvate Uptake Directs Glutamine into the TCA Cycle away from Glutathione Synthesis and Impairs Hepatocellular Tumorigenesis
Sean C. Tompkins, Ryan D. Sheldon, Adam J. Rauckhorst, et al.
Cell Reports (2019) Vol. 28, Iss. 10, pp. 2608-2619.e6
Open Access | Times Cited: 72
The yeast mitochondrial pyruvate carrier is a hetero‐dimer in its functional state
Sotiria Tavoulari, Chancievan Thangaratnarajah, Vasiliki Mavridou, et al.
The EMBO Journal (2019) Vol. 38, Iss. 10
Open Access | Times Cited: 60
Androgen-induced expression of DRP1 regulates mitochondrial metabolic reprogramming in prostate cancer
Yu Geon Lee, Yeji Nam, Kyeong Jin Shin, et al.
Cancer Letters (2019) Vol. 471, pp. 72-87
Closed Access | Times Cited: 58
The Role of Mitochondrial Fat Oxidation in Cancer Cell Proliferation and Survival
Matheus Oliveira, Marc Liesa
Cells (2020) Vol. 9, Iss. 12, pp. 2600-2600
Open Access | Times Cited: 58
Functional genomic studies reveal the androgen receptor as a master regulator of cellular energy metabolism in prostate cancer
Kevin Gonthier, Raghavendra Tejo Karthik Poluri, Étienne Audet‐Walsh
The Journal of Steroid Biochemistry and Molecular Biology (2019) Vol. 191, pp. 105367-105367
Closed Access | Times Cited: 57
Page 1 - Next Page

Scroll to top